InfuSystem (INFU) is poised for strong growth with rising profits, margin gains, and expansion in patient services. Read here ...

Litmus reaches a new funding milestone to accelerate industrial data innovation for AI at the edge, in the cloud, and ...

For entrepreneurs, understanding your strategic financial metrics could mean the difference between scaling up and shutting ...

This story was originally published by KFF Health News. Nationwide, states are racing to win their share of a new $50 billion rural health fund. But ...

November, the returns of initial public offerings have slowed, and the Renaissance IPO Index stands at a gain of 5.1% year to date, lagging the S&P 500 (up 16.4% by market price over ...

Q2 2026 Earnings Call November 12, 2025 4:00 AM ESTCompany ParticipantsSam GhezelbashSimon Michel - CEO & Member of ...

Have you ever walked into a house and felt an inexplicable sense of comfort, or perhaps a sudden sense of uneasiness? You ...

Like many Americans who have reached retirement age, you might be surprised to learn that Uncle Sam can tax your Social ...

Q4 revenue of $5.9 billion increased 8.3% as reported, 7.0% FXN and 3.9% organic Q4 GAAP and adjusted diluted EPS grew to $1.72 and $3.96, respectively FY25 ...

Reports record revenue of $21.2 million for the third quarter of 2025, an increase of $2.9 million, or 16%, compared to the same period in 2024. Reports record GAAP diluted EPS of $0.43 and non-GAAP ...

Insulet (PODD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...